ESPs containing Torus Biosystems
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
Point-of-care (POC) testing refers to diagnostic lab tests that can be performed rapidly, reliably, and easily at or near the point of care. Starting with a biological sample, POC tests detect or quantify certain analytes ‚Äî such as infectious agents, cardiac markers, and blood glucose ‚Äî to inform clinical decision making.
When was Torus Biosystems founded?
Torus Biosystems was founded in 2019.
Where is Torus Biosystems's headquarters?
Torus Biosystems's headquarters is located at 125 CambridgePark Drive, Cambridge.
What is Torus Biosystems's latest funding round?
Torus Biosystems's latest funding round is Series A.
How much did Torus Biosystems raise?
Torus Biosystems raised a total of $28.89M.
Who are the investors of Torus Biosystems?
Investors of Torus Biosystems include Technology Crossover Ventures and Northpond Ventures.
Who are Torus Biosystems's competitors?
Competitors of Torus Biosystems include Visby Medical, Baebies, Cardea Bio, MeMed, Accellix, Inflammatix, Oxford Nanopore Technologies, LumiraDx, Cue Health, Roche Holding and 22 more.
You May Also Like
Accellix develops fully automated, cost-effective, actionable cell-based analysis, 24/7 at the point of need, to a broad range of users. Its Accellix single-use cartridge analysis system provides results in less than 30 minutes, requires minimal training, and does not require users to deal with biological reagents, sample preparation, and complex data analysis.
Visby Medical is transforming the order of diagnosis and treatment for infectious diseases so clinicians can test, talk with, and treat the patient in a single visit. The company’s technology development program culminated in an instrument-free, single-use PCR platform that rapidly tests for serious infections. Originally developed for sexually transmitted infections, the Company’s FDA-cleared, CLIA-waived Sexual Health Click Test for women returns accurate results within 28 minutes. Visby Medical technology also offers the Visby Medical COVID-19 Test, and its robust pipeline includes tests for other infectious diseases. It was founded in 2015 and is based in San Jose, California.
Lumos Diagnostics provides rapid, cost effective, and complete point-of-care (POC) diagnostic test solutions that utilize proprietary digital reader platforms to help healthcare professionals more accurately diagnose and manage diseases and medical conditions. Lumos provides assay development and manufacturing services for customized POC tests as well as directly develops, manufactures, and will commercialize a suite of Lumos-branded POC tests.
MeMed is a med-tech and bio-convergence firm that researches, develops, and commercializes diagnostic host immune response testing methods that address complex clinical dilemmas and improve patient outcomes.
Ellume is a digital diagnostics company that develops and commercializes connected products for healthcare professionals and consumers. The company has developed a new biosensor technology that features unique optoelectronics and biologics.
Weavr Health is dedicated to connecting people to health by simplifying sample collection and processing for healthcare.The Velvet device is designed so anyone, anywhere can easily collect high-quality samples without a phlebotomist. The Velvet device offers a smooth experience of blood self-collection for patients. It leverages a similar experience to traditional glucose testing, which >25% of people have experienced. Each device arrives with all that is needed to collect, package and ship quality samples to the lab for a convenient experience.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.